Back to search
FDAFDA · Food and drugs·Recall number D-1311-2020

Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx Only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46

Published June 24, 2020 · Recall initiated: June 16, 2020

Summary

FDA records drug Class II recall D-1311-2020, published June 24, 2020 and initiated June 16, 2020. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 333 bags; Lot: Lot #: 1220017764, exp. date June 24, 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Product was distributed to hospitals in PA and CA.
Lot
Lot #: 1220017764, exp. date June 24, 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx Only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46 recalled?

Yes. FDA published recall D-1311-2020 on June 24, 2020. Reported hazard: Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

What should I do if I have this product?

Voluntary: Firm initiated · Letter